NO994303L - Krystallinsk hydrert natriumsalt av (E)-4,6-diklor-3-(2-okso-1-fenylpyrrolidin-3-ylidenmetyl)-1H-indol-2-karboksylsyre - Google Patents
Krystallinsk hydrert natriumsalt av (E)-4,6-diklor-3-(2-okso-1-fenylpyrrolidin-3-ylidenmetyl)-1H-indol-2-karboksylsyreInfo
- Publication number
- NO994303L NO994303L NO994303A NO994303A NO994303L NO 994303 L NO994303 L NO 994303L NO 994303 A NO994303 A NO 994303A NO 994303 A NO994303 A NO 994303A NO 994303 L NO994303 L NO 994303L
- Authority
- NO
- Norway
- Prior art keywords
- sodium salt
- ylidenomethyl
- phenylpyrrolidin
- indole
- dichloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994303D0 NO994303D0 (no) | 1999-09-03 |
| NO994303L true NO994303L (no) | 1999-11-03 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994303A NO994303L (no) | 1997-03-05 | 1999-09-03 | Krystallinsk hydrert natriumsalt av (E)-4,6-diklor-3-(2-okso-1-fenylpyrrolidin-3-ylidenmetyl)-1H-indol-2-karboksylsyre |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (et) |
| JP (1) | JP2001513796A (et) |
| KR (1) | KR20000075907A (et) |
| CN (1) | CN1249750A (et) |
| AP (1) | AP9901637A0 (et) |
| AR (1) | AR011178A1 (et) |
| AU (1) | AU6825198A (et) |
| BG (1) | BG103779A (et) |
| BR (1) | BR9808305A (et) |
| CA (1) | CA2282851A1 (et) |
| CO (1) | CO4940415A1 (et) |
| EA (1) | EA199900710A1 (et) |
| EE (1) | EE9900387A (et) |
| GB (1) | GB9704498D0 (et) |
| HR (1) | HRP980114A2 (et) |
| HU (1) | HUP0002109A2 (et) |
| ID (1) | ID24207A (et) |
| IL (1) | IL131489A0 (et) |
| IS (1) | IS5166A (et) |
| NO (1) | NO994303L (et) |
| NZ (1) | NZ337315A (et) |
| OA (1) | OA11154A (et) |
| PE (1) | PE51399A1 (et) |
| PL (1) | PL335652A1 (et) |
| SK (1) | SK119699A3 (et) |
| TR (1) | TR199902117T2 (et) |
| WO (1) | WO1998039327A1 (et) |
| YU (1) | YU43499A (et) |
| ZA (1) | ZA981791B (et) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| RU2020100230A (ru) | 2017-06-12 | 2021-07-13 | Глитек Ллс. | Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/et unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE51399A1 (es) | 1999-06-07 |
| IL131489A0 (en) | 2001-01-28 |
| EA199900710A1 (ru) | 2000-04-24 |
| BR9808305A (pt) | 2000-05-16 |
| EE9900387A (et) | 2000-04-17 |
| ID24207A (id) | 2000-07-13 |
| HUP0002109A2 (hu) | 2001-04-28 |
| SK119699A3 (en) | 2000-05-16 |
| IS5166A (is) | 1999-08-27 |
| PL335652A1 (en) | 2000-05-08 |
| TR199902117T2 (xx) | 2000-03-21 |
| AU6825198A (en) | 1998-09-22 |
| OA11154A (en) | 2003-04-16 |
| CN1249750A (zh) | 2000-04-05 |
| NZ337315A (en) | 2001-02-23 |
| BG103779A (en) | 2000-06-30 |
| HRP980114A2 (en) | 1998-12-31 |
| JP2001513796A (ja) | 2001-09-04 |
| KR20000075907A (ko) | 2000-12-26 |
| EP0966463A1 (en) | 1999-12-29 |
| NO994303D0 (no) | 1999-09-03 |
| GB9704498D0 (en) | 1997-04-23 |
| CO4940415A1 (es) | 2000-07-24 |
| AP9901637A0 (en) | 1999-09-30 |
| ZA981791B (en) | 1999-09-03 |
| CA2282851A1 (en) | 1998-09-11 |
| WO1998039327A1 (en) | 1998-09-11 |
| AR011178A1 (es) | 2000-08-02 |
| YU43499A (sh) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2260337A1 (en) | Therapeutic agents | |
| TW200407287A (en) | A sulfonated amine acid derivative and the metalloproteinase inhibitor containing it (I) | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
| TR200201144T2 (tr) | NFKB aktivitesinin modülasyonu için ikame edilmiş indoller | |
| NO20022558L (no) | 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| IL135921A (en) | Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity | |
| TR200002605T2 (tr) | Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri | |
| EP1140900A4 (en) | PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS | |
| GB9514518D0 (en) | Guanidine salt inhibitors of NO synthase and cyclooxygenase | |
| TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| NO994303L (no) | Krystallinsk hydrert natriumsalt av (E)-4,6-diklor-3-(2-okso-1-fenylpyrrolidin-3-ylidenmetyl)-1H-indol-2-karboksylsyre | |
| IL142776A0 (en) | Use of phosphonoformic acid derivatives for treating infections | |
| PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
| JO2240B1 (en) | Method for preparing dithylidene derivatives | |
| TR199701604T2 (xx) | Pirol t�revleri i�in yeni ba�vuru | |
| IL142775A0 (en) | Use of phosphonoformic acid derivatives for treating infections | |
| EE200200227A (et) | Tüüp 1 naatrium-vesinik ioniidi inhibiitori kristallid | |
| GB9723905D0 (en) | Heterocyclic compounds having MMP and TNF inhibitory activity | |
| ATE56445T1 (de) | Pharmacologisch aktive propionylanilide. | |
| ATE188468T1 (de) | Antiherpetische peptidomimetische verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |